352 related articles for article (PubMed ID: 8233444)
21. Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study.
Dutta P; Singhal S; Sachdeva NK; Shah VN; Pathak A; Mukherjee KK; Bhansali A
J Assoc Physicians India; 2014 Aug; 62(8):686-90. PubMed ID: 25856936
[TBL] [Abstract][Full Text] [Related]
22. Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new competitive enzyme immunoassay.
Kratzsch J; Blum WF; Schenker E; Keller E; Jahreis G; Haustein B; Ventz M; Rotzsch W
Exp Clin Endocrinol; 1993; 101(3):144-9. PubMed ID: 8223982
[TBL] [Abstract][Full Text] [Related]
23. Acromegaly and serum insulin-like growth factor I.
Thorner MO
Horm Res; 2004; 62 Suppl 1():34-6. PubMed ID: 15761230
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and endocrine testing in acromegaly.
Chang-DeMoranville BM; Jackson IM
Endocrinol Metab Clin North Am; 1992 Sep; 21(3):649-68. PubMed ID: 1521517
[TBL] [Abstract][Full Text] [Related]
25. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
[TBL] [Abstract][Full Text] [Related]
26. Somatomedin-C in active and successfully treated acromegaly.
Knappe G; Hesse V; Jahreis G; Rohde W; Gerl H
Exp Clin Endocrinol; 1988 Mar; 91(1):2-6. PubMed ID: 3371416
[TBL] [Abstract][Full Text] [Related]
27. [Acromegaly and insulin-like growth factors].
Zapf J; Froesch ER
Schweiz Med Wochenschr; 1986 Jan; 116(3):71-7. PubMed ID: 3945791
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone (GH) secretory dynamics in a case of acromegalic gigantism associated with hyperprolactinemia: nonpulsatile secretion of GH may induce elevated insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels.
Yoshida T; Shimatsu A; Sakane N; Hizuka N; Horikawa R; Tanaka T
J Clin Endocrinol Metab; 1996 Jan; 81(1):310-3. PubMed ID: 8550769
[TBL] [Abstract][Full Text] [Related]
29. Clinical laboratory indices in the treatment of acromegaly.
Clemmons DR
Clin Chim Acta; 2011 Feb; 412(5-6):403-9. PubMed ID: 21075098
[TBL] [Abstract][Full Text] [Related]
30. Acromegalic gigantism with low serum level of growth hormone and elevated serum insulin-like growth factor-I.
Miyazaki R; Yoshida T; Sakane N; Yasuda T; Umekawa T; Kondo M; Shimatsu A; Hizuka N; Sano T
Intern Med; 1995 Mar; 34(3):183-7. PubMed ID: 7787324
[TBL] [Abstract][Full Text] [Related]
31. [Application of serum somatomedin C level to assess the disease activity in patients with acromegaly].
Liu R; Shi YF; Deng JY
Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):636-8, 659. PubMed ID: 1306459
[TBL] [Abstract][Full Text] [Related]
32. Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1.
Parfitt VJ; Flanagan D; Wood P; Leatherdale BA
Clin Endocrinol (Oxf); 1998 Nov; 49(5):647-52. PubMed ID: 10197081
[TBL] [Abstract][Full Text] [Related]
33. Normal insulin-like growth factor-I in an elderly woman with acromegaly and medical illness.
Jaffe LS; Rosen HN
Arch Intern Med; 1994 Jul; 154(13):1533-5. PubMed ID: 8018009
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis in acromegaly. Insulin-like growth factor as a parameter of activity].
Schatz H; Stracke H; Zapf J
Dtsch Med Wochenschr; 1983 Sep; 108(37):1391-5. PubMed ID: 6349961
[TBL] [Abstract][Full Text] [Related]
35. Biochemical markers of acromegalic activity.
Jasper H; Chervin A; Vitale M; Mella A; Ropelato G; Basso A
Medicina (B Aires); 1994; 54(1):25-30. PubMed ID: 7990682
[TBL] [Abstract][Full Text] [Related]
36. Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH.
Daughaday WH; Starkey RH; Saltman S; Gavin JR; Mills-Dunlap B; Heath-Monnig E
J Clin Endocrinol Metab; 1987 Oct; 65(4):617-23. PubMed ID: 3654910
[TBL] [Abstract][Full Text] [Related]
37. Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion.
Bates AS; Evans AJ; Jones P; Clayton RN
Clin Endocrinol (Oxf); 1995 Apr; 42(4):417-23. PubMed ID: 7750196
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of acromegaly: state of the art.
Kannan S; Kennedy L
Expert Opin Med Diagn; 2013 Sep; 7(5):443-53. PubMed ID: 23971897
[TBL] [Abstract][Full Text] [Related]
39. Insulin secretion and insulin-like growth factor-I levels in active and controlled acromegaly.
Hopkins KD; Holdaway IM
Clin Endocrinol (Oxf); 1992 Jan; 36(1):53-7. PubMed ID: 1559300
[TBL] [Abstract][Full Text] [Related]
40. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly.
Chen HS; Lin HD
J Endocrinol Invest; 1999 Feb; 22(2):98-103. PubMed ID: 10195375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
